Conclusions: The two paths are both safer and more effective compared with simple chemotherapy for patients with MDR-TB, while the percutaneous pulmonary biopsy path has a high rate of complication.

• 结论：经两种途径介导注药治疗MDR-TB的疗效相同，且均优于常规全身化疗，经皮肺穿刺注药并发症发生率高。